We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Clarification for the interpretation of the new elements within the Veterinary Medicines Regulations (VMRs), as amended, relating to combating antimicrobial resistance (AMR).
Guidance on the Batch Release Request scheme for an immunological veterinary medicine to be placed on the UK market.
VDEC developed a standardised assay reduce the development of antimicrobial resistance and improve patient treatment for tuberculosis.
Marburg virus is a Filovirus which, along with Ebola virus, can cause a severe and often fatal viral haemorrhagic fever (VHF).
Guidance for people aged 12 and over whose immune system means they are at higher risk of serious illness if they become infected with COVID-19.
The government has announced its new national action plan on antimicrobial resistance to protect people and animals from the risk of drug-resistant infections.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
The mycology reference laboratory (MRL) provides a comprehensive laboratory service for the diagnosis and management of fungal infections.
Information for people who wish to apply to release a vaccine or a blood product to market in the UK.
Applications received to amend the specification of a patent under sections 27 and 75 before the court and the Office.
Increase virus replication fitness and decrease pandemic potential
The approach the MHRA intends to take for products approved or pending in decentralised procedure (DCP) or mutual recognition procedures (MRP).
Guidance on the Genetic Modification Inspectorate (GMI) seed audit programme for companies in England that import, produce or market seed.
A proactive, collaborative, agile and the first of its kind approach to identifying and addressing the challenges faced by AI as a Medical Device (AIaMD).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).